Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (61-70 of 293) with videos related to

Pageof 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinomaJ A Sparano, N Robert, P Silverman, et al.
Blood|May 15, 1993
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimenJ A Sparano, P H Wiernik, M Strack, et al.
Experimental Hematology & Oncology|September 10, 2013
Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controlsEsther A Peterson, Eirini Pectasides, Shabana Shabbeer, et al.
Medical Oncology (Northwood, London, England)|June 27, 1998
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Medical Oncology (Northwood, London, England)|January 1, 1994
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancerP H Wiernik, N T Sklarin, J P Dutcher, et al.
Breast Cancer Research and Treatment|June 16, 2009
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualizationJoseph A Sparano, Gabriel N Hortobagyi, Julie R Gralow, et al.
Clinical Breast Cancer|March 20, 2002
Microvessel density and p53 overexpression in young women with breast cancer: a case-control studyB Kalfon, S Fineberg, Y Gu, et al.
Bone Marrow Transplantation|January 1, 1995
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignanciesA Khalil, N Ciobanu, J A Sparano, et al.
Blood|August 15, 2002
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)Joseph A Sparano, Edie Weller, Tipu Nazeer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 3, 1999
Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical centerJ A Sparano, K Anand, J Desai, et al.
Pageof 30

Showing results (61-70 of 293) with videos related to

Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinomaJ A Sparano, N Robert, P Silverman, et al.
Blood|May 15, 1993
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimenJ A Sparano, P H Wiernik, M Strack, et al.
Experimental Hematology & Oncology|September 10, 2013
Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controlsEsther A Peterson, Eirini Pectasides, Shabana Shabbeer, et al.
Medical Oncology (Northwood, London, England)|June 27, 1998
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.
Medical Oncology (Northwood, London, England)|January 1, 1994
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancerP H Wiernik, N T Sklarin, J P Dutcher, et al.
Breast Cancer Research and Treatment|June 16, 2009
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualizationJoseph A Sparano, Gabriel N Hortobagyi, Julie R Gralow, et al.
Clinical Breast Cancer|March 20, 2002
Microvessel density and p53 overexpression in young women with breast cancer: a case-control studyB Kalfon, S Fineberg, Y Gu, et al.
Bone Marrow Transplantation|January 1, 1995
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignanciesA Khalil, N Ciobanu, J A Sparano, et al.
Blood|August 15, 2002
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493)Joseph A Sparano, Edie Weller, Tipu Nazeer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 3, 1999
Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical centerJ A Sparano, K Anand, J Desai, et al.
Pageof 30